BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 23207411)

  • 1. Synthesis and biological evaluation of a new series of phenothiazine-containing protein farnesyltransferase inhibitors.
    Abuhaie CM; Ghinet A; Farce A; Dubois J; Gautret P; Rigo B; Belei D; Bîcu E
    Eur J Med Chem; 2013 Jan; 59():101-10. PubMed ID: 23207411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide chemistry applied to a new family of phenothiazine-containing inhibitors of human farnesyltransferase.
    Dumitriu GM; Ghinet A; Bîcu E; Rigo B; Dubois J; Farce A; Belei D
    Bioorg Med Chem Lett; 2014 Jul; 24(14):3180-5. PubMed ID: 24856060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenothiazine-based CaaX competitive inhibitors of human farnesyltransferase bearing a cysteine, methionine, serine or valine moiety as a new family of antitumoral compounds.
    Dumitriu GM; Bîcu E; Belei D; Rigo B; Dubois J; Farce A; Ghinet A
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4447-52. PubMed ID: 26372651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New farnesyltransferase inhibitors in the phenothiazine series.
    Belei D; Dumea C; Samson A; Farce A; Dubois J; Bîcu E; Ghinet A
    Bioorg Med Chem Lett; 2012 Jul; 22(14):4517-22. PubMed ID: 22738631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of a new series of N-ylides as protein farnesyltransferase inhibitors.
    Abuhaie CM; Ghinet A; Farce A; Dubois J; Rigo B; Bîcu E
    Bioorg Med Chem Lett; 2013 Nov; 23(21):5887-92. PubMed ID: 24054122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of new phenothiazine derivatives bearing a pyrazole unit as protein farnesyltransferase inhibitors.
    Baciu-Atudosie L; Ghinet A; Farce A; Dubois J; Belei D; Bîcu E
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6896-902. PubMed ID: 23036952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New indolizine-chalcones as potent inhibitors of human farnesyltransferase: Design, synthesis and biological evaluation.
    Moise IM; Ghinet A; Belei D; Dubois J; Farce A; Bîcu E
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3730-4. PubMed ID: 27282741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of imidazole-containing analogues of farnesyl pyrophosphate and evaluation of their biological activity on protein farnesyltransferase.
    Coudray L; de Figueiredo RM; Duez S; Cortial S; Dubois J
    J Enzyme Inhib Med Chem; 2009 Aug; 24(4):972-85. PubMed ID: 19555171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and biological evaluation of substituted dioxodibenzothiazepines and dibenzocycloheptanes as farnesyltransferase inhibitors.
    Gilleron P; Wlodarczyk N; Houssin R; Farce A; Laconde G; Goossens JF; Lemoine A; Pommery N; Hénichart JP; Millet R
    Bioorg Med Chem Lett; 2007 Oct; 17(19):5465-71. PubMed ID: 17827015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid-phase synthesis and pharmacological evaluation of a library of peptidomimetics as potential farnesyltransferase inhibitors: an approach to new lead compounds.
    Gilleron P; Millet R; Houssin R; Wlodarczyk N; Farce A; Lemoine A; Goossens JF; Chavatte P; Pommery N; Hénichart JP
    Eur J Med Chem; 2006 Jun; 41(6):745-55. PubMed ID: 16647166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guiding farnesyltransferase inhibitors from an ECLiPS library to the catalytic zinc.
    Huang CY; Stauffer TM; Strickland CL; Reader JC; Huang H; Li G; Cooper AB; Doll RJ; Ganguly AK; Baldwin JJ; Rokosz LL
    Bioorg Med Chem Lett; 2006 Feb; 16(3):507-11. PubMed ID: 16289818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and characterization of piperazinedione-based dual protein inhibitors for both farnesyltransferase and geranylgeranyltransferase-I.
    Qiao Y; Gao J; Qiu Y; Wu L; Guo F; Lo KK; Li D
    Eur J Med Chem; 2011 Jun; 46(6):2264-73. PubMed ID: 21440964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3D-QSAR with the aid of pharmacophore search and docking-based alignments for farnesyltransferase inhibitors.
    Vaidya M; Weigt M; Wiese M
    Eur J Med Chem; 2009 Oct; 44(10):4070-82. PubMed ID: 19515462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New asymmetric synthesis of protein farnesyltransferase inhibitors via palladium-catalyzed cross-coupling reactions of 2-iodo-imidazoles.
    Kerhervé J; Botuha C; Dubois J
    Org Biomol Chem; 2009 May; 7(10):2214-22. PubMed ID: 19421463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of benzophenone-based farnesyltransferase inhibitors as novel antimalarials.
    Kohring K; Wiesner J; Altenkämper M; Sakowski J; Silber K; Hillebrecht A; Haebel P; Dahse HM; Ortmann R; Jomaa H; Klebe G; Schlitzer M
    ChemMedChem; 2008 Aug; 3(8):1217-31. PubMed ID: 18470859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure-activity relationships of novel benzofuran farnesyltransferase inhibitors.
    Asoh K; Kohchi M; Hyoudoh I; Ohtsuka T; Masubuchi M; Kawasaki K; Ebiike H; Shiratori Y; Fukami TA; Kondoh O; Tsukaguchi T; Ishii N; Aoki Y; Shimma N; Sakaitani M
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1753-7. PubMed ID: 19217288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New protein farnesyltransferase inhibitors in the 3-arylthiophene 2-carboxylic acid series: diversification of the aryl moiety by solid-phase synthesis.
    Lethu S; Bosc D; Mouray E; Grellier P; Dubois J
    J Enzyme Inhib Med Chem; 2013 Feb; 28(1):163-71. PubMed ID: 22233543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based design of imidazole-containing peptidomimetic inhibitors of protein farnesyltransferase.
    Ohkanda J; Strickland CL; Blaskovich MA; Carrico D; Lockman JW; Vogt A; Bucher CJ; Sun J; Qian Y; Knowles D; Pusateri EE; Sebti SM; Hamilton AD
    Org Biomol Chem; 2006 Feb; 4(3):482-92. PubMed ID: 16446806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel indolizine derivatives with unprecedented inhibitory activity on human farnesyltransferase.
    Dumea C; Belei D; Ghinet A; Dubois J; Farce A; Bîcu E
    Bioorg Med Chem Lett; 2014 Dec; 24(24):5777-5781. PubMed ID: 25453818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel inhibitor of farnesyltransferase with a zinc site recognition moiety and a farnesyl group.
    Tanaka A; Radwan MO; Hamasaki A; Ejima A; Obata E; Koga R; Tateishi H; Okamoto Y; Fujita M; Nakao M; Umezawa K; Tamanoi F; Otsuka M
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3862-3866. PubMed ID: 28666734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.